New Cancer Center at Guy's Hospital in London to be Equipped with Varian TrueBeam Treatment Machines
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vascular Solutions Inc. (VASC) To Contact The Firm
Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vascular Solutions, Inc. - VASC
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vascular Solutions Inc.
AmeriHealth New Jersey Expands Co-Branded Product Offering With Two Additional South Jersey Hospitals
AAR CEO Named to the President's Advisory Council on Doing Business in Africa
Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...
The combination makes plenty of sense and should better position the firm for the future.